A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.
R. Charles Coombes(Cancer Research UK), A Villar-Grimalt, Giordano Beretta(Humanitas Gavazzeni), Philip S. Schein, J. Wils(Laurentius Ziekenhuis), C E Chilvers, D. Amadori(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Judith M. Bliss(Institute of Cancer Research), H. Cortés-Funes(Centre Hospitalier René-Dubos), Annemie Rutten(GZA Ziekenhuizen Campus Sint-Augustinus)
Cited by 156
Related Papers
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers
|UCL Discovery (University College London)|1997|1k
Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck
|Journal of Clinical Oncology|2005|491
Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer
|Journal of Clinical Oncology|2005|454
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer
|JAMA Oncology|2019|425